Ann: Appendix 4C Quarterly & Company Update, page-34

I am saying that if they fail to deliver on what they put in an announcement they lose the faith of shareholders.

The current lack of buying in PAA suggests that atm prospective buyers dont have enough faith to buy in and it wouldnt take much non delivery for the sp to tumble.

As I said before I dont expect them to give results of the trial just yet but do expect them to deliver on the recruitment of new patients as this is vital information as no new patients means no further higher doze trials.

The trial was to include 12 to 15 patients and so far all we know is that one patient on the lower dose is in the trial.

DYOR